629 related articles for article (PubMed ID: 10706111)
21. Comparison of the chemopreventive efficacies of garlic powders with different alliin contents against aflatoxin B1 carcinogenicity in rats.
Bergès R; Siess MH; Arnault I; Auger J; Kahane R; Pinnert MF; Vernevaut MF; le Bon AM
Carcinogenesis; 2004 Oct; 25(10):1953-9. PubMed ID: 15180943
[TBL] [Abstract][Full Text] [Related]
22. The Cap'n'Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes.
McMahon M; Itoh K; Yamamoto M; Chanas SA; Henderson CJ; McLellan LI; Wolf CR; Cavin C; Hayes JD
Cancer Res; 2001 Apr; 61(8):3299-307. PubMed ID: 11309284
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of aflatoxin B1-induced initiation of hepatocarcinogenesis in the rat by green tea.
Qin G; Gopalan-Kriczky P; Su J; Ning Y; Lotlikar PD
Cancer Lett; 1997 Jan; 112(2):149-54. PubMed ID: 9066721
[TBL] [Abstract][Full Text] [Related]
24. Protection against aflatoxin B1-induced hepatocarcinogenesis in F344 rats by 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione (oltipraz): predictive role for short-term molecular dosimetry.
Roebuck BD; Liu YL; Rogers AE; Groopman JD; Kensler TW
Cancer Res; 1991 Oct; 51(20):5501-6. PubMed ID: 1680553
[TBL] [Abstract][Full Text] [Related]
25. Modification of aflatoxin B1 binding to DNA in vivo in rats fed phenolic antioxidants, ethoxyquin and a dithiothione.
Kensler TW; Egner PA; Trush MA; Bueding E; Groopman JD
Carcinogenesis; 1985 May; 6(5):759-63. PubMed ID: 3924431
[TBL] [Abstract][Full Text] [Related]
26. Regulation of carbonyl-reducing enzymes in rat liver by chemoprotectors.
Ellis EM; Judah DJ; Neal GE; O'Connor T; Hayes JD
Cancer Res; 1996 Jun; 56(12):2758-66. PubMed ID: 8665510
[TBL] [Abstract][Full Text] [Related]
27. Sequential dietary exposure to aflatoxin B1 and fumonisin B1 in F344 rats increases liver preneoplastic changes indicative of a synergistic interaction.
Qian G; Tang L; Lin S; Xue KS; Mitchell NJ; Su J; Gelderblom WC; Riley RT; Phillips TD; Wang JS
Food Chem Toxicol; 2016 Sep; 95():188-95. PubMed ID: 27430420
[TBL] [Abstract][Full Text] [Related]
28. Dietary carotenoids inhibit aflatoxin B1-induced liver preneoplastic foci and DNA damage in the rat: role of the modulation of aflatoxin B1 metabolism.
Gradelet S; Le Bon AM; Bergès R; Suschetet M; Astorg P
Carcinogenesis; 1998 Mar; 19(3):403-11. PubMed ID: 9525273
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of the cancer chemopreventive potency of dithiolethione analogs of oltipraz.
Roebuck BD; Curphey TJ; Li Y; Baumgartner KJ; Bodreddigari S; Yan J; Gange SJ; Kensler TW; Sutter TR
Carcinogenesis; 2003 Dec; 24(12):1919-28. PubMed ID: 14555609
[TBL] [Abstract][Full Text] [Related]
30. Glucocorticoid regulation of polycyclic aromatic hydrocarbon induction of cytochrome P450IA1, glutathione S-transferases, and NAD(P)H:quinone oxidoreductase in cultured fetal rat hepatocytes.
Sherratt AJ; Banet DE; Prough RA
Mol Pharmacol; 1990 Feb; 37(2):198-205. PubMed ID: 2304451
[TBL] [Abstract][Full Text] [Related]
31. Comparative activities of glutathione-S-transferase and dialdehyde reductase toward aflatoxin B1 in livers of experimental and farm animals.
Tulayakul P; Sakuda S; Dong KS; Kumagai S
Toxicon; 2005 Aug; 46(2):204-9. PubMed ID: 15964045
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of aflatoxin B1-hepatocarcinogenesis in rats by beta-naphthoflavone.
Gurtoo HL; Koser PL; Bansal SK; Fox HW; Sharma SD; Mulhern AI; Pavelic ZP
Carcinogenesis; 1985 May; 6(5):675-8. PubMed ID: 3924427
[TBL] [Abstract][Full Text] [Related]
33. Chemoprevention by inducers of carcinogen detoxication enzymes.
Kensler TW
Environ Health Perspect; 1997 Jun; 105 Suppl 4(Suppl 4):965-70. PubMed ID: 9255588
[TBL] [Abstract][Full Text] [Related]
34. Protection of salvia miltiorrhiza against aflatoxin-B1-induced hepatocarcinogenesis in Fischer 344 rats dual mechanisms involved.
Liu J; Yang CF; Wasser S; Shen HM; Tan CE; Ong CN
Life Sci; 2001 Jun; 69(3):309-26. PubMed ID: 11441922
[TBL] [Abstract][Full Text] [Related]
35. Complete protection against aflatoxin B(1)-induced liver cancer with a triterpenoid: DNA adduct dosimetry, molecular signature, and genotoxicity threshold.
Johnson NM; Egner PA; Baxter VK; Sporn MB; Wible RS; Sutter TR; Groopman JD; Kensler TW; Roebuck BD
Cancer Prev Res (Phila); 2014 Jul; 7(7):658-65. PubMed ID: 24662598
[TBL] [Abstract][Full Text] [Related]
36. Effect of cell proliferation on initiation of aflatoxin B1-induced enzyme altered hepatic foci in rats and hamsters.
Hiruma S; Qin GZ; Gopalan-Kriczky P; Shinozuka H; Sato K; Lotlikar PD
Carcinogenesis; 1996 Nov; 17(11):2495-9. PubMed ID: 8968068
[TBL] [Abstract][Full Text] [Related]
37. Changes in hepatic cytosolic glutathione S-transferase activity and expression of its class-P during prenatal and postnatal period in rats treated with aflatoxin B1.
Fatemi F; Allameh A; Dadkhah A; Forouzandeh M; Kazemnejad S; Sharifi R
Arch Toxicol; 2006 Sep; 80(9):572-9. PubMed ID: 16501953
[TBL] [Abstract][Full Text] [Related]
38. Effect of dietary protein level on aflatoxin B1 actions in the liver of weanling rats.
Mandel HG; Judah DJ; Neal GE
Carcinogenesis; 1992 Oct; 13(10):1853-7. PubMed ID: 1423844
[TBL] [Abstract][Full Text] [Related]
39. cDNA cloning, expression and activity of a second human aflatoxin B1-metabolizing member of the aldo-keto reductase superfamily, AKR7A3.
Knight LP; Primiano T; Groopman JD; Kensler TW; Sutter TR
Carcinogenesis; 1999 Jul; 20(7):1215-23. PubMed ID: 10383892
[TBL] [Abstract][Full Text] [Related]
40. Cloning of cDNAs from fetal rat liver encoding glutathione S-transferase Yc polypeptides. The Yc2 subunit is expressed in adult rat liver resistant to the hepatocarcinogen aflatoxin B1.
Hayes JD; Nguyen T; Judah DJ; Petersson DG; Neal GE
J Biol Chem; 1994 Aug; 269(32):20707-17. PubMed ID: 8051171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
